2019 Young Investigator Symposium

ECOG-ACRIN Features Eight Young Investigators at its 2019 Symposium

The ECOG-ACRIN Cancer Research Group held its annual Young Investigator Symposium on Thursday, October 25, 2019 in Fort Lauderdale. Eight early-career investigators presented their science to attendees of the organization’s fall group meeting and responded to attendees’ questions. The symposium is a professional mentoring event for clinical, translational or basic researchers whose research projects are selected on the basis of scientific innovation, significance, and the potential for clinical impact.

ECOG-ACRIN gave awards of distinction to two individuals, taking into consideration the merit of their research, quality of the presentation delivery, command of the topic, and ability to respond to related questions. The recipients of the awards are listed first, below, followed by the remaining presenters.

	Distinction Award for Clinical Research Samilia Obeng-Gyasi, MD, MPH Assistant Professor of Surgery Indiana University School of Medicine Impact of Insurance and Socioeconomic Status on Clinical Outcomes in Therapeutic Clinical Trials for Breast Cancer
	Distinction Award for Translational Research Chaoyuan (Charlie) Kuang, MD, PhD Fellow, Hematology-Oncology University of Pittsburgh Cancer Institute Correlative Studies for UPCI 14-118: A Phase II Study of Pembrolizumab in Combination with Azacitidine in Patients with Refractory Metastatic Colorectal Cancer
	Benjamin Bleiberg, BS Medical Student Researcher University of Texas Southwestern Medical School Electronic Medical Record (EMR) QTc Alert Associations with Acute Cancer Patient Mortality within 10 Days by Primary Malignancy Site and Demographic Factors
	Sanjay Chandrasekaran, MD Fellow, Department of Hematology & Oncology Winship Cancer Institute of Emory University PI3K Delta and Gamma Inhibition as a Treatment for Cutaneous Melanoma
	Samuel J. Galgano, MD Assistant Professor, Department of Radiology University of Alabama at Birmingham [18F]Fluciclovine-PET/MRI Use in Monitoring Response to Androgen Deprivation Therapy in Men with Prostate Cancer Following Initial Staging
	Wade Iams, MD Assistant Professor of Medicine, Thoracic Oncology Vanderbilt University Medical Center Blood-Based Surveillance Monitoring of Cell-Free DNA from Patients with Small Cell Lung Cancer Detects Disease Relapse and Predicts Death in Patients with Limited Stage Disease
	Erica C. Nakajima, MD Fellow, Medical Oncology Johns Hopkins Hospital Dynamic Heterogeneity in [18F]-FDG PET Radiomic Features Before and After Neoadjuvant Nivolumab and Association with Major Pathologic Response in Early State Non-Small Cell Lung Cancer
	Abhishek Tripathi, MD Assistant Professor of Medicine, Hematology & Oncology University of Oklahoma Stephenson Cancer Center Prognostic Significance and Immune Correlates of CD73 Expression in Renal Cell Carcinoma

Return to Home | Return to Young Investigator Home Page